Novanta reported strong financial results for the second quarter of 2021, with double-digit growth in sales, bookings, and profit. Customer demand accelerated in advanced industrial and medical application areas, with bookings increasing 77% year over year. The company is raising its full year guidance.
GAAP revenue was $167.5 million, a 15.8% increase year-over-year.
GAAP consolidated net income was $11.7 million.
GAAP diluted earnings per share was $0.33.
Adjusted EBITDA was $37.0 million, compared to $30.8 million in the second quarter of 2020.
For the third quarter of 2021, the Company expects GAAP revenue of approximately $165 million to $170 million. The Company expects Adjusted EBITDA to be in the range of $35 million to $37 million and Adjusted Diluted EPS to be in the range of $0.55 to $0.60. For the full year 2021, the Company expects GAAP revenue of approximately $660 million to $670 million. The Company expects Adjusted EBITDA to be in the range of $140 million to $143 million and Adjusted Diluted EPS to be in the range of $2.30 to $2.40.